Very proud to launch our official website of the Canadian Bronchiectasis and NTM registry! Excited to continue its growth in the years to come! 🫁 @CTS_SCT@UCalgary: bxconnect.org
Both 10mg and 25mg brensocatib has been approved in the US for treatment of bronchiectasis.
In the absence of official guidance, Chuck Daley and i comment on optimal dosing, concluding that 25mg should be the preferred dose for patients
@ATSBlueEditoracademic.oup.com/ajrccm/advance…
In non-CF bronchiectasis, the central question is no longer whether mucoactives work but for whom, under what circumstances, and at what cost in treatment burden. Explore these questions further in an article from the Bronchiectasis Section in CHEST Physician: hubs.la/Q049z4qs0
Putting the recent CLEAR airway clearance trial into perspective. How does it fit in with what we know about airway clearance therapies in bronchiectasis?
chestphysician.org/airway-clearan…@ProfJDChalmers
Going to try to keep my Twitter/X algorithm free of extremism
Only focus on medicine and interacting with interesting colleagues around the world.
Wish me luck!
New Interactive Education: Unmasking bronchiectasis – From guidelines to the bedside: expert case reflections
Join the experts as they discuss the critical need for high-quality, case-based learning to help clinicians improve practice in bronchiectasis: channel.ersnet.org/media-121211-u…